Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will…

S&P 500, Nasdaq Extend Win Streaks

Major stock indexes ended mostly higher Wednesday, building on a long run of gains.  The S&P…

Amazon to Offer Lower-Cost Primary Care to Prime Members in Latest Healthcare Push

Updated Nov. 8, 2023 8:38 am ET Amazon.com is turning to Prime members to bolster its…

WSJ News Exclusive | LVMH to Buy Eyewear Brand Favored by the Stars

PARIS—LVMH Moët Hennessy Louis Vuitton has agreed to buy Los Angeles-based eyewear maker Barton Perreira, part…

Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore

CVS and Walgreens pharmacy employees say they are overworked, understaffed, and more liable to make prescription…

Obesity Drug Demand Outstrips Supply

Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as…

GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings

Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit…

Never Mind Covid, Investors Want a Pfizer Obesity Pill

Some of this year’s best performers in the healthcare sector are companies expected to profit from…

Sanofi Plans to Spin Off Consumer-Healthcare, Pharma Businesses

Updated Oct. 27, 2023 4:03 am ET Sanofi said it plans to spin off its consumer-healthcare…

‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

Merck and Pfizer are the latest big pharma companies to invest in this booming area.